suPAR - a future risk marker in bacteremia. [J Intern Med. 2011] - PubMed

Save items

loading

Related citations in PubMed

Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. [J Intern Med. 2011]
Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study.
Huttunen R, Syrjänen J, Vuento R, Hurme M, Huhtala H, Laine J, Pessi T, Aittoniemi J. J Intern Med. 2011 Jul; 270(1):32-40. Epub 2011 Mar 21.
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. [J Intern Med. 2010]
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.
Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, Langkilde A, Petersen J, Pielak T, Møller LN, Jeppesen J, et al. J Intern Med. 2010 Sep; 268(3):296-308. Epub 2010 May 28.
Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability. [Clin Biochem. 2010]
Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability.
Olson FJ, Thurison T, Ryndel M, Høyer-Hansen G, Fagerberg B. Clin Biochem. 2010 Jan; 43(1-2):124-30. Epub 2009 Oct 12.
Review suPAR: the molecular crystal ball. [Dis Markers. 2009]
Review suPAR: the molecular crystal ball.
Thunø M, Macho B, Eugen-Olsen J. Dis Markers. 2009; 27(3):157-72.
Review The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer. [APMIS. 1999]
Review The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer.
Brünner N, Nielsen HJ, Hamers M, Christensen IJ, Thorlacius-Ussing O, Stephens RW. APMIS. 1999 Jan; 107(1):160-7.

See reviews... See all...

Cited by 2 PubMed Central articles

The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis. [Biomark Insights. 2012]
The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis.
Gustafsson A, Ljunggren L, Bodelsson M, Berkestedt I. Biomark Insights. 2012; 7:39-44. Epub 2012 Apr 10.
Review suPAR as a prognostic biomarker in sepsis. [BMC Med. 2012]
Review suPAR as a prognostic biomarker in sepsis.
Donadello K, Scolletta S, Covajes C, Vincent JL. BMC Med. 2012 Jan 5; 10:2. Epub 2012 Jan 5.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

suPAR - a future risk marker in bacteremia.
suPAR - a future risk marker in bacteremia.
J Intern Med. 2011 Jul ;270(1):29-31. doi: 10.1111/j.1365-2796.2011.02372.x. Epub 2011 Mar 24 .

PubMed
Transcranial Doppler in cerebral vasospasm.
Transcranial Doppler in cerebral vasospasm.
Neurosurg Clin N Am. 1990 Apr ;1(2):319-28.

PubMed
A comparison of early versus late initiation of renal replacement therapy in cri...
A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis.
Crit Care. 2011 ;15(1):R72. Epub 2011 Feb 25 .

PubMed
Serum choline esterase and liver function among a group of organophosphorus pest...
Serum choline esterase and liver function among a group of organophosphorus pesticides sprayers in Egypt.
J Toxicol Clin Exp. 1990 Nov-Dec ;10(7-8):427-35.

PubMed
Clinical review: Prothrombin complex concentrates--evaluation of safety and thro...
Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity.
Crit Care. 2011 ;15(1):201. Epub 2011 Jan 12 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

suPAR - a future risk marker in bacteremia.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information